Israel Englander Vir Biotechnology, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,248,131 shares of VIR stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,248,131

Previous 641,327 94.62%

Holding current value

$12.7 Million

Previous $6.5 Million 71.0%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $4.63 Million - $7.68 Million	606,804 Added 94.62%	1,248,131 $11.1 Million
Q1 2024 May 15, 2024	BUY	$8.6 - $11.9 $1.99 Million - $2.75 Million	231,270 Added 56.4%	641,327 $6.5 Million
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $3.18 Million - $4.22 Million	410,057 New	410,057 $4.13 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $261,777 - $362,796	11,760 Added 25.74%	57,451 $1.34 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $4.86 Million - $6.87 Million	-243,479 Reduced 84.2%	45,691 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $7.27 Million - $12.4 Million	-398,029 Reduced 57.92%	289,170 $5.58 Million
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $77.5 Million - $108 Million	-4,060,995 Reduced 85.53%	687,199 $17.5 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $80.1 Million - $151 Million	3,780,369 Added 390.6%	4,748,194 $122 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $24.9 Million - $43.4 Million	802,652 Added 485.95%	967,825 $40.5 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $5.3 Million - $8.29 Million	-151,977 Reduced 47.92%	165,173 $7.19 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $10.7 Million - $14.1 Million	276,771 Added 685.43%	317,150 $15 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $1.72 Million - $5.42 Million	-65,300 Reduced 61.79%	40,379 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $2.7 Million - $4.58 Million	105,679 New	105,679 $2.83 Million
Q3 2020 Nov 16, 2020	SELL	$28.28 - $53.6 $317,358 - $601,499	-11,222 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $312,981 - $537,084	11,222 New	11,222 $460,000

Others Institutions Holding VIR

# of Institutions

222

Shares Held

85.8M

Call Options Held

231K

Put Options Held

132K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.35B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account